Proliferative retinopathy in duchenne muscular dystrophy and its response to bevacizumab

Clinical and Experimental Ophthalmology, 05/25/2012

The authors report the first case of proliferative retinopathy associated with Duchenne Muscular Dystrophy treated with intra–vitreal bevacizumab. The patient is a twenty–three year old quadriplegic male with ventilatory failure and cardiomyopathy requiring intermittent bilevel positive airway pressure for the past twelve months. The patient had complained of two weeks of loss of vision in the right eye associated with pain and photophobia.

Print Article Summary